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Ten-eleven translocation (Tet) family proteins convert
5-methylcytosine to 5-hydroxymethylcytosine. We
show that mouse embryonic stem cells (ESCs)
depleted of Tet1 and/or Tet2 by RNAi exhibit short
telomeres and chromosomal instability, concomitant
with reduced telomere recombination. Tet1 and
Tet2 double-knockout ESCs also display short telo-
meres but to a lesser extent. Notably, Tet1/2/3
triple-knockout ESCs show heterogeneous telo-
mere lengths and increased frequency of telomere
loss and chromosomal fusion. Mechanistically, Tets
depletion or deficiency increases Dnmt3b and de-
creases 5hmC levels, resulting in elevated methyl-
ation levels at sub-telomeres. Consistently, knock-
down of Dnmt3b or addition of 2i (MAPK and GSK3b
inhibitors), which also inhibits Dnmt3b, reduces telo-
mere shortening, partially rescuing Tet1/2 defi-
ciency. Interestingly, Tet1/2 double or Tet1/2/3 triple
knockout in ESCs consistently upregulates Zscan4,
whichmaycounteract telomere shortening. Together,
Tet enzymes play important roles in telomere mainte-
nance and chromosomal stability of ESCs by modu-
lating sub-telomeric methylation levels.INTRODUCTION
Ten-eleven translocation (Tet) family proteins oxidize 5-methyl-
cytosine (5mC) to 5-hydroxymethylcytosine (5hmC), an interme-
diate that can lead to DNA demethylation (Kohli and Zhang,
2013; Tahiliani et al., 2009). TET proteins are implicated in
diverse biological processes, including epigenetic regulation of
gene transcription, embryonic development, stem cell function
and pluripotency, and cancer, but the underlying mechanismsCel
This is an open access article undstill remain to be defined (review Pastor et al., 2013; Costa
et al., 2013; Dawlaty et al., 2013; Ficz et al., 2011; Ito et al.,
2010; Koh et al., 2011). Tet proteins regulate genome-wide re-
programming by modulating DNA methylation levels (Wu et al.,
2011; Xu et al., 2011) and affect embryonic stem cell (ESC) plu-
ripotency and differentiation (Costa et al., 2013; Ficz et al., 2011;
Ito et al., 2010).
Roles of Tets in vivo were tested by generating Tets knockout
(KO) mice. Intriguingly, if they survive from early development,
Tets-deficient mice mostly do not show observable phenotypes
(Dawlaty et al., 2013; Li et al., 2011). Mice mutant for either Tet1
or Tet2 are viable or show only neuronal deficiencies (Dawlaty
et al., 2011; Ko et al., 2011; Li et al., 2011; Zhang et al., 2013).
Some Tet1mutant mice have a slightly smaller body size at birth
(Dawlaty et al., 2011), whichmight reflect a developmental delay,
and also are subfertile (Yamaguchi et al., 2012). These enzymes
may have overlapping roles in development. KO of both Tet1 and
Tet2 suggests that Tet1/2 do not play a significant role in embry-
onic development (Dawlaty et al., 2013; Hu et al., 2014). This
seems to be difficult to reconcile with the roles of Tets in self-
renewal and pluripotency of ESCs/induced pluripotent stem
cells (iPSCs) (Costa et al., 2013; Ficz et al., 2011; Ito et al., 2010).
Telomeresmaintain genomic stability and are critical for unlim-
ited self-renewal and pluripotency of ESCs and iPSCs (Huang
et al., 2011; Marion et al., 2009). Mouse telomeres are quite
long, and telomerase Terc- deficient mice following several gen-
erations of breeding acquire striking phenotypes associated with
telomere dysfunction, including developmental defects, aging,
and cancer (Blasco et al., 1997; Herrera et al., 1999; Rudolph
et al., 1999). Tet1 and Tet2 double-knockout (DKO) mice, if sur-
vived from embryonic lethal, show partially penetrant perinatal
lethality or reduced fertility with small ovaries (Dawlaty et al.,
2013). These defects mimic those of telomere-shortened, late-
generation, telomerase-deficient mice that also exhibit small
body, defective neurogenesis, and infertility (Hao et al., 2005;
Herrera et al., 1999).
Nevertheless, ESCs isolated from the first generation (G1)
telomerase-deficient mice already exhibit telomere dysfunctionl Reports 15, 1809–1821, May 24, 2016 ª 2016 The Author(s) 1809
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Telomere Shortening and Chromosomal Instability of Mouse ESCs Depleted of Tet1 and/or Tet2
(A) Representative telomere FISH images of Tet1 or Tet2 stable KD and Tet1 and Tet2 double KD (abbreviated as Tet1/2 KD) ESCs (NF2 Nanog-GFP ESCs). Blue
dots, chromosomes stained with DAPI; green dots, telomeres. Red arrow indicates telomere loss and chromosomal fusion.
(legend continued on next page)
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and significantly reduced developmental potency (Huang et al.,
2011), indicating that the high proliferation rates of cultured
ESCs can accelerate telomere shortening. Functional telomeres
are required for the genome-wide epigenetic regulation of ESC
differentiation (Pucci et al., 2013). Tet depletion also skews
ESC differentiation (Dawlaty et al., 2014; Koh et al., 2011). It re-
mains unclear whether Tet1 or/and Tet2 regulate telomere
lengths. Here, we report that Tet1 and Tet2 enzymes are required
to maintain telomere function and chromosomal stability of
mouse ESCs.
RESULTS
Depletion of Tet1 and Tet2 in ESCs Leads to Telomere
Shortening and Chromosomal Instability
Tet1 and Tet2, but not Tet3, are highly expressed in ESCs (Ito
et al., 2010; Koh et al., 2011) and iPSCs, in contrast to mouse
embryonic fibroblasts (MEFs) or most somatic tissues (data not
shown). Tet3 is highly expressed in MEFs and various somatic
tissues but low in ESCs/iPSCs. To test whether Tet1 and Tet2
play a role in telomere maintenance, we depleted Tet1 and/or
Tet2 in mouse ESCs by RNAi using at least two sequences spe-
cifically targeting Tet1, Tet2, or both genes (Ficz et al., 2011; Ito
et al., 2010; Experimental Procedures). The RNAi effectively
depleted Tet mRNA and protein levels (Figures S1A–S1E), and
Tet1 or Tet2 depletion alone slightly or minimally affected
expression of pluripotency genes Oct4 and Nanog (Figures
S1F–S1H). Depletion of both Tet1 and Tet2 reduced expression
of pluripotency genes, particularly Nanog, but these ESCs main-
tained colony formation without morphologic signs of differenti-
ation (Figures S1I–S1K).
We found that telomeres were shortened in ESCs depleted of
either Tet1 or Tet2 andmore profoundly so in double-knockdown
(DKD) ESCs as estimated by telomere quantitative fluorescence
in situ hybridization (FISH) assay (Figures 1A and 1B) and inde-
pendently validated by quantitative real-time PCR method (Fig-
ure 1C). Moreover, frequency of telomere loss and chromosome
fusion increased in ESCs depleted of both Tet1 and Tet2 (Figures
1D and 1E). These observations were confirmed in another inde-
pendent ESC line (BF10) following depletion of both Tet1 and
Tet2 (Figures 1F–1I). Cell proliferation was slightly reduced by
double knockdown (KD) of Tet1 and Tet2 (Figure S1L).
To assess theeffect ofTet1/Tet2depletion ondevelopment,we
injected Tet1/Tet2 DKD or control ESCs into blastocysts and
compared rates of chimera formation. Chimeric pups with black
and albino coat were obtained only from mock control ESCs,
also confirmed by microsatellite genotyping (representative gel(B) Histogram displays distribution of relative telomere length shown as TFU
depletion of Tet1 and/or Tet2. Heavy black bars on y axis indicated by red arrows s
passage 6 following stable KD. The medium telomere length (green bars) is sho
quantified for each group.
(C) Relative telomere length shown as T/S ratio by qPCR. Three replicates are sh
(D) Frequency per chromosome spread of telomere signal-free ends, indicative o
(E) Frequency per chromosome spread of chromosomal fusion after Tet1 and Te
(F–I) Double KD of Tet1 and Tet2 in anothermouse ESC line (BF10) leads to telome
by QFISH (F), T/S ratio by qPCR (G), frequency of telomere signal-free ends (H
following stable double KD of Tet1/2. Data represent mean ± SEM.
*p < 0.05; **p < 0.01; ***p < 0.001, compared with mock ESC controls. See alsoimage data shown), but not from Tet1 and Tet2 DKD ESCs (Fig-
ures S2A–S2E). Our data support previous findings that Tet1
and Tet2 regulate ESC self-renewal and pluripotency (Costa
et al., 2013; Ficz et al., 2011; Ito et al., 2010; Koh et al., 2011).
Furthermore, we show that telomere shortening is a general phe-
nomenon resulting fromdepletion of Tet1 and/or Tet2, suggesting
that Tet1 and Tet2 regulate telomere maintenance in ESCs.
Tet1 and Tet2 Regulate Telomere Recombination
To explore the mechanisms underlying telomere dysfunction
arising from depletion of Tet1 and Tet2, we initially analyzed
expression of genes related to telomerase, a primary pathway
for extension of telomeres. Transient KD of Tet1, Tet2, or both
did not immediately reduce expression of major telomerase
genes Tert and Terc (Figure S1A). Despite telomere shortening,
stable KD of Tet1 or Tet2 alone also did not cause appreciable
changes in expression of telomerase genes Tert and Terc or
in telomerase activity. However, we noticed that stable KD of
both Tet1 and Tet2 caused variations in expression of Tert and
Terc and in telomerase activity (Figures 2A–2D). Extension of
telomeres by telomerase usually takes place at a slow rate.
Hence, minor reduction in telomerase activity would be an
unlikely explanation for the rapid telomere loss associated with
Tet1 and Tet2 depletion.
Telomeres also can be elongated by alternative lengthening
of telomere (ALT) pathways involving telomere recombination
(Bailey et al., 2004; Bechter et al., 2004; Conomos et al., 2013;
London˜o-Vallejo et al., 2004). Telomere elongation by recombi-
nation is characterized by telomere sister chromatid exchange
(TSCE) revealed by chromosome orientation (CO)-FISH analysis
(Bailey et al., 2004; Bechter et al., 2004; Liu et al., 2007; Zalzman
et al., 2010). Frequency of TSCE was reduced upon Tet1 or Tet2
KD, and particularly upon Tet1/2 double KD, compared to mock
controls in two independent ESC lines (Figures 2E and 2F).More-
over, expression of genes associated with telomere recombina-
tion (Conomos et al., 2013; Zalzman et al., 2010), particularly
Dmc1 and Smc1b, was consistently decreased following deple-
tion of Tet1 and/or Tet2 (Figures 2G and 2H). These data suggest
that Tet1 and Tet2 play a role in telomere recombination and
elongation.
Telomere Shortening in Tet1 or Tet1/Tet2 DKO ESCs
KD experiments by short hairpin RNA (shRNA) could produce
incomplete silencing or off-target effects. Thus, we attempted
to knock out Tet1 gene in ESCs by CRISPR/Cas9 and analyzed
telomeres. Tet1 was effectively knocked out, as evidenced by
sequencing and qPCR analysis, which showed only minimalby telomere quantitative fluorescence in situ hybridization (QFISH) following
how frequency of telomere signal-free ends. Telomere length wasmeasured at
wn as mean ± SD above each panel. More than 15 chromosome spread was
own.
f telomere loss after Tet1 and Tet2 KD.
t2 KD.
re shortening and dysfunction, shown as telomere length distribution histogram
), and chromosomal fusion (I). Telomere length was measured at passage 11
Figure S1.
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Figure 2. Effects of Tet1 or Tet2 KD or Tet1/2
Double KD on Telomerase and Telomere
Sister Chromatic Exchange
(A–D) Expression of telomerase genes and telome-
rase activity following KD of Tet1/Tet2. (A and C)
qRT-PCR analysis of expression levels of Tert and
Terc in NF2 (A) and BF10 ESCs (C). (B and D)
Telomerase activity by TRAP assay of NF2 (B) and
BF10 ESCs (D). Lysis buffer served as negative
controls.
(E and F) TSCE (indicated by white arrows) revealed
by CO-FISH analysis of independent ESC lines from
twomouse strains following Tet1/2 depletion. (Right
panel) Frequency of TSCE in Tet1/2 DKD ESC,
compared with mock controls, based on the num-
ber of TSCE dot/per chromosome spread (n) is
shown.
(G and H) qRT-PCR analysis of expression levels of
genes for telomere recombination, Dmc1, Rad50,
and Smc1b. *p < 0.05; **p < 0.01; ***p < 0.001,
compared with Mock KD controls. Data represent
mean ± SEM.
See also Figure S2.
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Tet1 expression (Figures S3A–S3C). Telomeres were shortened
in Tet1KO ESCs, compared with wild-type (WT) ESCs, as shown
by quantitative FISH (QFISH) and Southern blot analysis (Figures
S3D and S3E).
We also measured telomere length in Tet1 and Tet2 DKO ESC
lines, generated by gene targeting method (Hu et al., 2014). The
Tet1/2 DKO ESCs enabled study of effects of complete and
prolonged Tet deficiency on telomeres. 2i (mitogen-activated
protein kinase [MAPK] inhibitor and GSK3b inhibitor), which
decrease MAPK and activate b-catenin/Wnt signaling, provided
transcriptional and epigenomic foundations for naive ground
state pluripotency (Ficz et al., 2013; Marks et al., 2012; Ying
et al., 2008) and were used to maintain self-renewal of Tet1/
Tet2 DKO ESCs (Hu et al., 2014). Tet1/Tet2 DKO ESCs mani-
fested increased levels of DNA methylation and dramatically
reduced levels of 5hmC by immunofluorescence and thus high
5mC/5hmC ratio (Figures 3A and 3B), consistent with the null
status of Tet1 and Tet2. Tet1/Tet2 DKO ESCs harbored shorter
telomeres than did the WT ESCs, regardless of 2i (Figure 3C).
However, contrary to our expectation that telomeres would
shorten more in Tet1/2 DKO ESCs than in DKD ESCs, telomeres
of DKO ESCs shortened to lesser extent compared to those of
KD ESCs (Figure 1; see below). However, we need to emphasize
that the KD and KO ESCs were derived from different back-
grounds and origins. In addition, telomere loss and chromo-
somal fusions did not differ between Tet1/Tet2 DKO and WT
ESCs cultured in the presence of 2i and slightly increased in
Tet1/Tet2DKO compared withWT ESCs cultured in the absence
of 2i (Figures 3D and 3E). The average shorter telomeres in Tet1/
Tet2 DKO ESCs compared to WT ESCs were confirmed by
qPCR method (Figure 3F). Furthermore, Tet1/Tet2 DKO ESCs
exhibited increased frequency of TSCE (Figures 3G and 3H),
suggesting that telomere recombination might be involved in
telomere length regulation in these cells.
Triple KO of Tet1, Tet2, and Tet3 in ESCs Induces
Telomere Loss and Chromosomal Fusion
Recently, Tet1/2/3 triple-knockout (TKO) ESCs generated by
CRISPR/Cas9were shown to exhibit longer telomeres compared
with WT ESCs (Lu et al., 2014). We sought to assess telomere
functions from two additional Tet1/2/3 TKO ESC lines (Hu et al.,
2014; Dawlaty et al., 2014). Tet1/2/3 TKO ESCs from both
M.M.D. and G.X. labs formed nice colonies similar to those of
Tet1/2 DKO and WT ESCs (Figure S4A). Remarkably, telomere
loss and chromosome fusion were more elevated in Tet1/2/3
TKO ESCs than in Tet1/2 DKO ESCs and WT ESCs (Figures
4A–4C). Over 90% of chromosome spreads from the TKO
ESCsprovided by theM.M.D. lab and 15% from theG.X. lab con-
tained at least one chromosome fusion (Figures 4A–4C). Coinci-
dently, the TKO ESCs from M.M.D. lab do not contribute to
chimeras, whereas the TKOESCs from theG.X. lab do. However,
the average telomere lengths of Tet1/2 DKO ESCs from M.M.D.
lab did not differ from those of WT ESCs, and telomeres were
slightly shorter in Tet1/2/3 TKO ESCs than in Tet1/2 DKO ESCs
and WT ESCs (Figures 4A and 4D). High frequency of telomere
loss can contribute to the average shorter telomeres in the TKO
ESCs. Tet1/2 DKO ESCs from G.X. lab exhibited shorter telo-
meres compared to WT ESCs, but telomeres of Tet1/2/3 TKOESCs were longer than those of Tet1/2 DKO ESCs (Figures 4A
and 4D). The average telomere length obtained by QFISH
method was validated by Southern blot analysis, which mea-
sures telomeres shown as terminal restriction fragment (TRF)
(Figures 4E and S4B). Also, TRF confirmed the shorter average
telomeres in Tet1/2 DKD ESC lines (NF2 and BF10). It is impor-
tant to note that QFISH can measure even rare short telo-
meres, whereas TRF measures primarily mean telomere length.
Notably, heterogeneous telomere lengths and distributions
were observed in TKO ESCs compared with WT ESCs (Figures
4A and 4D), suggesting that an ALT pathway might have been
activated.
Tet1 and Tet2 Regulate Sub-telomeric DNA Methylation
Genome-wide mapping of 5hmC in ESCs shows enrichment at
start sites of genes whose promoters carry histone 3 lysine 27 tri-
methylation (H3K27me3) and histone 3 lysine 4 trimethylation
(H3K4me3) marks, but not at sites of heterochromatic H3K9 or
H4K20 trimethylation, where 5mC preferentially occupies (Mik-
kelsen et al., 2007; Pastor et al., 2011). Fluorescence micro-
scopy using antibodies to 5mC or 5hmC also identified that
5mC foci co-localized with heterochromatic region marked
by Hoechst, whereas 5hmC distributed non-specifically in the
nuclei, and notably more intensively stained 5mC foci with
heterochromatin were found in Tet1/2 DKO ESCs (Figure 3A).
To reveal the enrichment of 5mC or 5hmC at sub-telomeres,
we performedmethylated DNA immunoprecipitation (MeDIP) us-
ing primers specific for sub-telomeres of chromosomes 7 and
13. The 5mC levels did not increase at these sub-telomeric loci
following double KD of Tet1/2 in ESCs, compared with mock
KD controls (Figure 5A), but were elevated following double KO
of Tet1/2 in ESCs (Figure 5B). Likewise, heterochromatic telo-
mere regions were co-localized with fewer 5mC foci in WT
ESCs, and the frequency of telomere regions co-localized with
more strongly stained 5mC foci nearly doubled in Tet1/Tet2
DKO ESCs (Figure 5C). Levels of 5hmC were reduced at sub-
telomeres of chromosome 13 following double KD of Tet1/2
and more reduced at both chromosomes in the DKO ESCs (Fig-
ures 5A and 5B). These data corroborate with findings of high
5mC/5hmC ratio in the DKO ESCs with minimal levels of 5hmC
(Figures 3A and 3B).
Moreover, we analyzed methylation levels by bisulfite seq-
uencing using primers specific for sub-telomeres of selected
chromosomes 1, 7, and 13 (Figure 5D). DNA methylation levels
at sub-telomeres of chromosomes 1 and 7 were elevated in
Tet1/Tet2 DKO ESCs, compared with WT ESCs. Moreover, 2i
noticeably reduced DNA methylation levels at sub-telomeres
of all three chromosomes tested, consistent with reduced
Dnmt3a/b protein levels (Figure S7A; immunofluorescence of
Dnmt3b data not shown). Hence, Tet1 and Tet2 play a critical
role in regulating methylation levels at sub-telomeres, impacting
telomere recombination.
To examine whether telomerase also is involved in telomere
length regulation by Tets, we knocked out Terc in Tet1/2 DKO
ESCs by CRISPR/Cas9. Terc deficiency further shortened telo-
meres in Tet1/2 DKO ESCs (Figure S5), suggesting that lack of
both Tet1 and Tet2 shortens telomeres independently of telome-
rase Terc.Cell Reports 15, 1809–1821, May 24, 2016 1813
Figure 3. Tet1 and Tet2 DKO ESCs Exhibit Reduced Telomere Shortening, in Association with Increased TSCE
(A) Immunofluorescence of DNA methylation (5mC) and DNA hydroxymethylation (5hmC) in Tet1 and Tet2 DKO ESCs. The scale bar represents 20 mm.
(B) 5mC/5hmC relative fluorescence intensity ratio estimated using ImageJ software.
(C) Histogram shows distribution of relative telomere length as TFU by QFISH. Heavy black bars on y axis show frequency of telomere signal-free ends. The
medium telomere length (green bars) also is shown as mean ± SD above each panel.
(D and E) Frequency of telomere loss and chromosome fusion in WT and DKO ESCs cultured in the presence or absence of 2i (2i+ or 2i).
(F) Relative telomere length of WT and DKO ESCs shown as T/S ratio by qPCR.
(G) Micrographs showing TSCE (indicated by white arrows) by CO-FISH analysis.
(H) Frequency of TSCE, based on the number of TSCE dot/per chromosome spread. *p < 0.05; ***p < 0.001, compared with WT ESCs. Data represent
mean ± SEM.
See also Figure S3.
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Figure 4. TKO of Tet1, Tet2, and Tet3 in ESCs Results in Telomere Dysfunction and Prominent Chromosomal Fusion
(A) Telomere QFISH images of ESCs, showing telomere loss (arrowhead) and chromosomal fusion (arrow) in Tet1/2/3 TKO ESCs, compared with WT and Tet1/2
DKO ESCs.
(B) Frequency of telomere loss per chromosome spread. Approximately 30 spreads were counted for each genotype.
(C) Frequency of chromosomal fusion per chromosome spread.
(D) Histogram showing distribution of relative telomere length as TFU by QFISH. Heavy black bars on y axis show frequency of telomere signal-free ends. The
medium telomere length (green bars) also is shown as mean ± SD above each panel.
(E) Telomere length distribution shown as TRF by Southern blot analysis. KD, Tet1/2 double KD ESCs. *p < 0.05; ***p < 0.001. Data represent mean ± SEM.
See also Figure S4.Dnmt3b Is Involved in Telomere Length Regulation by
Tet1 and Tet2
Tet1 and Tet2 regulate genome-wide DNA methylation levels by
inducing DNA hydroxymethylation, and Tet1 deficiency results inan increase in 5mC levels atmany Tet1-enriched regions (Wuand
Zhang, 2011; Xu et al., 2011). Notably, Tet1 occupies the pro-
moter region of DNA methyltransferase Dnmt3b and represses
Dnmt3b, and consistently, Tet1 depleted cells showed increasedCell Reports 15, 1809–1821, May 24, 2016 1815
Figure 5. Tet1 and Tet2 Regulate Sub-telomeric Methylation
(A) MeDIP assay of 5mC or 5hmC levels at sub-telomeres of chr7 and chr13 in mock and Tet1/2 DKD ESCs. The b-actin locus served as control.
(B) MeDIP assay of 5mC or 5hmC levels at sub-telomeres of chr7 and chr13 in WT and Tet1/2 DKO ESCs. *p < 0.05; ***p < 0.001.
(C) Representative images showing telomeres (green), 5mC (red), or merged fluorescence (yellow) in wild-type (WT) and Tet1 and Tet2 DKO ESCs and frequency
of telomeres co-localized with 5mC foci. The scale bar represents 10 mm.
(D) Bisulfite sequencing analysis of CpG methylation at sub-telomeric regions of chromosomes 1, 7, and 13, respectively. Open circles indicate unmethylated
cytosines, filled circles methylated cytosines, and crosses mutation of cytosines. p < 0.05, considered significant differences, compared with WT ESCs. Data
represent mean ± SEM.
See also Figure S5.Dnmt3b, but notDnmt3a, levels bymicroarray analysis (Freuden-
berg et al., 2012). In linewith this, stable KD of both Tet1 and Tet2
led to increased 5mC and reduced 5hmC levels as quantified by
immunofluorescence microscopy (Figure S6A) coincided with
upregulation of Dnmt3b (Figures S6B–S6F).1816 Cell Reports 15, 1809–1821, May 24, 2016To test whether high levels of Dnmt3b are implicated in Tet1/2
depletion-mediated telomere shortening, we knocked down
Dnmt3b in Tet1 and Tet2 DKD ESCs. The efficacy of Dnmt3b
KD was confirmed by western blot and immunofluorescence
microscopy (Figures 6A and 6B). Dnmt3b KD reduced DNA
Figure 6. KD of Dnmt3b Elongates Telomeres of ESCs Depleted of both Tet1 and Tet2
(A) Western blot analysis of Tet1, Tet2, and Dnmt3b protein levels in control and KD ESC lines (BF10). b-actin served as a loading control. Two different shRNAs
sequences against Dnmt3b were used to achieve stable Dnmt3b KD ESCs.
(B) Immunofluorescence microscopy of Dnmt3b in control and Tet1/Tet2 KD and Dnmt3b KD ESCs. The scale bar represents 10 mm.
(C and D) KD of Dnmt3b reduces 5mC levels in Tet1- and Tet2-depleted ESCs. (C) Immunofluorescence microscopy of DNA methylation (5mC) and DNA hy-
droxymethylation (5hmC) relative levels between control KD, Tet1/2 double KD, and Dnmt3b/Tet1/2 triple KD ESCs (BF10) is shown. The scale bar represents
10 mm. (D) Relative methylation quantification by 5mC/5hmC ratio estimated using ImageJ software (upper panel) or by FACS analysis (lower panel) is shown.
(E) Histogram showing distribution of relative telomere length as TFU by QFISH at P10 after KD of Dnmt3b. Heavy black bars on y axis indicated by red arrows
show frequency of telomere signal-free ends. The medium telomere length (green bars) also is shown as mean ± SD above each panel.
(F) Relative telomere length shown as T/S ratio by qPCR. Three replicates are shown.
(G and H) Frequency of telomere loss per chromosome spread (G) and chromosomal fusion per chromosome spread after Dnmt3b KD in BF10 ESCs depleted of
Tet1 and Tet2 (H). *p < 0.05; **p < 0.01, compared with Mock ESC controls. Data represent mean ± SEM.
See also Figures S6 and S7.methylation levels (Figures 6C and 6D) and elongated telomeres
(Figures 6E and 6F). Staining for 5mC co-localized with hetero-
chromatic foci, contrary to diffuse nuclear staining of 5hmC
(Figure 6C). Telomeres elongated in the Tet1/2/Dnmt3b KD
ESCs cultured for ten additional passages compared to Tet1
and Tet2 DKD ESCs as analyzed by telomere QFISH and
qPCR. Also, frequency of telomere loss and chromosomal fusion
was reduced in Tet1/2/Dnmt3b KD ESCs, in comparison withTet1 and Tet2 double KD alone (Figures 6G and 6H). Together,
these data further support the notion that Tet1 and Tet2 sup-
press Dnmt3b and regulate telomere maintenance.
Implication of Zscan4 and Dnmt3b in Tet Signaling
It is intriguing to note that Tet1/Tet2 DKO ESCs show telomere
lengthening compared with Tet1/Tet2 DKD ESCs. Above data
suggest that telomere recombination as shown by TSCE couldCell Reports 15, 1809–1821, May 24, 2016 1817
be the major pathway leading to rapid and remarkable changes
in telomere lengths. Zscan4 is involved in telomere recombina-
tion and elongation (Zalzman et al., 2010). Additionally, the
sub-telomeric DNA methylation mediated by Dnmt3a and
Dnmt3b negatively regulates telomere recombination and telo-
mere lengths (Gonzalo et al., 2006). Tet1/Tet2 DKO ESCs
exhibited increased frequency of TSCE (Figures 3G and 3H).
Therefore, we examined whether and how Zscan4 and
Dnmt3a/3b are implicated in Tet signaling. Dnmt3a protein levels
seemed to be stable, but Dnmt3b was noticeably elevated in
Tet1/Tet2 DKO ESCs, and 2i decreased Dnmt3a and Dnmt3b
protein (Figure S7A) and 5mC levels (Figures 3A and 3B),
consistent with the notion that 2i reducesDnmt3a/3b to promote
hypomethylation and enhances TET1/2 activity (and conse-
quently 5hmC levels) and ‘‘passive’’ loss of DNA methylation
(Ficz et al., 2013; Leitch et al., 2013). Tet1/Tet2 DKO ESCs ex-
pressed higher levels of Zscan4 by immunoblot than did WT
ESCs, and 2i reduced Zscan4 protein levels in both WT and
DKO ESCs (Figure S7A), also validated by immunofluorescence
microscopy and fluorescence-activated cell sorting (FACS) anal-
ysis (data not shown). Increased expression of Zscan4 and TSCE
might counteract and thus reduce telomere shortening resulting
from Dnmt3b-mediated sub-telomeric methylation in Tet1/2
DKO ESCs.
To understand whether Tet1 and Tet2 directly impact Zscan4
and Dnmt3a/3b, we performed KD experiments. Tet1 and Tet2
transient KD for 48 hr immediately upregulated Dnmt3b, but
not Dnmt3a, as confirmed by qPCR analysis (Figure S7B) and
also by western blot (Figure S7C). Zscan4 protein levels also
declined following Tet1 and Tet2 transient KD.
Also, we compared expression of Zscan4 and Dnmt3b in Tets
DKO and TKO ESC lines. Dnmt3b and 3a levels were higher in
ESCs from M.M.D lab than from G.X. lab (Figure S7D). Zscan4
was expressed at even higher levels in both TKO ESC lines by
qPCR analysis and by western blot than in their corresponding
DKO ESCs (Figures S7E and S7F). Additionally, Zscan4 expres-
sion levels were relatively higher in ESCs from M.M.D. lab than
those from G.X. lab. Dnmt3b levels were higher in DKO ESCs
than in WT ESCs from G.X. lab and declined in TKO ESCs
compared with DKO ESCs. By FACS analysis of Zscan4 immu-
nofluorescence,WT ESCs originated fromM.M.D showed higher
percentage of Zscan4+ ESCs than did those from G.X. lab
(5.62% versus 1.76%; Figure S7G). Moreover, DKO and TKO
ESCs from M.M.D. exhibited further increasing proportion of
Zscan4+ cells (11.15% and 21.16%, respectively) with some
reduction of Zscan4 fluorescence intensity, compared with
WT ESCs. DKO and TKO ESCs from G.X. lab also displayed
increasing proportion of Zscan4+ cells but to less extent
(4.51% and 7.74%), with increased Zscan4 fluorescence inten-
sity (Figure S7G). Zscan4 expression levels were higher in
ESCs from M.M.D. than those from G.X. lab, supporting the
qPCR and western blot data (Figures S7E and S7F).
These data suggest that ESC lines established from different
labs can have various expression levels of Dnmt3b and Zscan4
in terms of the proportion and intensity, causing variations in
the average telomere length. Regardless of 2i and the average
telomere length, Tets TKO ESCs exhibit elevated telomere loss
and chromosome instability.1818 Cell Reports 15, 1809–1821, May 24, 2016DISCUSSION
We show that Tets play important roles in regulation of telomeres
and maintenance of chromosomal stability. Tet1/2 double
KD rapidly induces expression of Dnmt3b, concomitant with
reduced levels of 5hmC and TSCE, leading to telomere short-
ening and chromosomal instability. Complete lack of Tet1/2 by
double KO also results in elevated expression of Dnmt3b,
accompanied with highly elevated ratio of 5mC/5hmC and min-
imal 5hmC. Low or minimal 5hmC levels dramatically reduce
hydroxymethylation levels at sub-telomeres. Elevated levels of
Dnmt3b can lead to telomere shortening, whereas increased
Zscan4 induces TSCE and telomere recombination, and this
partly compensates for telomere shortening in Tet1/2 DKO
ESCs, showing reduced telomere shortening on average. Exces-
sive expression of Zscan4 in Ter1/2/3 TKO ESCs may contribute
to heterogeneous telomere elongation by ALT. Abnormally high
levels of Zscan4, together with high Dnmt3b/5mC levels, can
cause heterogeneous telomere elongation and shortening, telo-
mere loss, and high frequency of chromosome fusion arising in
Tet1/2/3 TKO ESCs. Consistently, 2i reduces levels of both
Dnmt3a/3b and Zscan4, such that telomere length and function
are partly recovered and chromosome fusion reduced.
Depletion of Tet1 and Tet2 by KD induces rapid telomere
shortening, in association with reduced incidence of TSCE. Pre-
sumably, the KD experiments provide immediate and direct
impact upon Tet1/Tet2 depletion, whereas data obtained from
the KO cell lines may represent indirect or long-term effects of
Tet deficiency. High expression levels of Tet1 and Tet2 in mouse
ESCs likely play critical roles in maintaining low methylation at
sub-telomeres, favoring telomere elongation by recombination.
In agreement, DNA methylation mediated by DNMT3A/3B
and TETs interact preferentially at heterochromatic region and
silencing repeats (Smith and Meissner, 2013). Our data on the
role of Tet enzymes in telomere function also may explain the
seemingly contradictory functions of Tets reported in ESCplurip-
otency and differentiation (more dramatic phenotypes by KD or
KO of Tet1 or Tet2 alone in ESCs) versus development in vivo
(mild or no immediate phenotypes of Tet1 or/and Tet2 KO
mice). Tet1, Tet2, and even Tet3 seem to have overlapping or
compensatory roles in regulation of telomeres, differentiation,
and pluripotency of ESCs in vitro and development and differen-
tiation in vivo. Tet1 and Tet2 also are highly expressed in iPSCs
and required for reprogramming and iPSC induction (Doege
et al., 2012; Gao et al., 2013) and may play a similar role in telo-
mere maintenance and chromosomal stability of iPSCs.
Telomere shortening can be partly rescued by high expression
of Zscan4 in ESCs without Tets. It will be interesting to test
whether telomeres continue to shorten during differentiation of
ESCs and fetal embryonic development and in animals without
Tets and Zscan4 expression. Zscan4 is specifically expressed
in two-cell embryos and sporadically in small subpopulation
(1%–5%) of ESCs and inactivated in differentiated cells including
fibroblasts (Dan et al., 2014; Zalzman et al., 2010). Appropriate
expression of Zscan4 is required for telomere recombination
and effective lengthening of ESCs, whereas excessive Zscan4
can disrupt telomere length homeostasis, leading to heteroge-
neous telomere elongation and loss and chromosome fusion
(Dan et al., 2014). Zscan4 is inactivated with differentiation of
ESCs, and Tet1/2 DKO and Tet1/2/3 TKO ESCs likely lose the
compensatory mechanisms of telomere maintenance following
differentiation.
The proportion of ESCs that express Zscan4 and Zscan4
levels could affect average telomere lengths. In the recent report
(Lu et al., 2014), the basal levels of Zscan4 seem to be low in
ESCs, with only 0.23%ofWT ESCpopulation positive for Zscan4
by FACS and a significant increase in Zscan4+ cells in TKO ESCs
(1.54%; by 6.7-fold) could lead to high TSCE and longer telo-
meres. Moreover, methods for ESC derivation and gene deletion
as well as ESC passage number could influence telomere
lengths. Telomeres lengthen to some degree in normal mouse
ESCs/iPSCs with increasing passages (Huang et al., 2011; Mar-
ion et al., 2009). The passage number could vary among these
Tet DKO or TKO ESC lines from different labs. Differences in
telomere lengths between Tet KD and DKO ESCs may also be
explained by ESC passage numbers when the telomeres
were analyzed. In KD experiments, the passage number was
controlled and the comparison made for the same passages of
KD and mock ESC controls.
Our data suggest that both Zscan4 and Dnmt3b-mediated
DNA methylation are involved in telomere recombination
and length regulation by Tets. Dnmt3b expression is rapidly
increased and Zscan4 reduced following transient KD of Tet1
and Tet2. Dnmt3b levels also are increased in Tet1/2 stable dou-
ble KD and in Tet1/2 DKO ESCs. In addition, recombination-
related genes such as Smc1b and Dmc1 are downregulated
following Tet1/2 double KD, consistent with the array data
from Tet1 KO in ESCs, showing reduced expression of Smc1b
and two-cell genes including Zscan4 (Gm397), Tcstv1, and
Tcstv3 (Dawlaty et al., 2011). We show that Dnmt3b KD in
Tet1/2-depleted ESCs can partly rescue telomere shortening.
In agreement, ESCs deficient for DNAmethyltransferases exhibit
significantly elongated telomeres facilitated by recombination
(Gonzalo et al., 2006).
Telomere loss and chromosome fusion resulting from Tets defi-
ciency may have implication in aging and cancer. The shortest
telomere, not the average telomere length, drives chromosome
instability, affecting cell viability and transformation (der-Sarkis-
sian et al., 2004; Hemann et al., 2001). Tet1 and Tet2mutation or
deletion leads to tumorigenesis (Abdel-Wahab et al., 2009; Cour-
onne´ et al., 2012; Hsu et al., 2012; Huang et al., 2013; Ko et al.,
2010; Lemonnier et al., 2012; Li et al., 2011; M€uller et al., 2012;
Quivoron et al., 2011). We find that Tet deficiency leads to hetero-
geneous telomere elongation and shortening and chromosomal
instability, defects that are associated with tumorigenesis and
aging (Artandi et al., 2000; Blasco, 2007; Rudolph et al., 1999).
Further investigation of Tet enzymes in the context of telomere
biology may have significant implications for aging and cancer.
EXPERIMENTAL PROCEDURES
ESCs and Culture
NF2 ESC lines were derived fromNanog-EGFP transgenicmice andBF10 ESC
lines from B6C3F1mice (Chen et al., 2009; Liu et al., 2011). Tet1 and Tet2DKO
or Tet1/2/3 TKO ESCs from G.X. lab were generated from C57BL/6X129
mouse background and validated by genotyping and absent Tet1 and Tet2
proteins or all Tets by western blot (Hu et al., 2014). Tet1/2 DKO, Tet1/2/3TKO, and WT ESCs generated from M.M.D. lab (Dawlaty et al., 2013,
2014) also were used for telomere analysis. ESCs were routinely cultured on
mitomycin-C-treated MEF feeder in ESC culture medium consisting of KO
DMEM supplemented with 20% fetal bovine serum (FBS) (ESC quality; Hy-
clone), 1,000 U/ml leukemia inhibitory factor (LIF) (ESGRO; Chemicon),
0.1 mM non-essential amino acids, 0.1 mM b-mercaptoethanol, 1 mM L-gluta-
mine, and penicillin (100 U/ml) and streptomycin (100 mg/ml; Dan et al., 2014).
J1 ESCs were cultured without MEF feeder. ESC lines from G.X. or M.M.D. lab
were cultured as described (Hu et al., 2014; Dawlaty et al., 2013, 2014).
KD of Tet1, Tet2, or Dnmt3b by RNAi
Tet1, Tet2, and Dnmt3b shRNA sequences shown as below were synthesized
and cloned into pSIREN-RetroQ, according tomanufacturer’s instructions. KD
of Tet1, Tet2, or both by RNAi was achieved using at least two sequences
specifically targeting to the Tet1 or Tet2 (Ficz et al., 2011; Ito et al., 2010).
The mock KD shRNA without sequence homology to mouse genes served
as negative control. pSIREN-RetroQ control and KD plasmid (2 mg) were
introduced into Plat-E cells using lipofectamine transfection reagent accord-
ing to the manufacturer’s recommendation. Viruses were collected with
0.45 mm membrane filter at 48 hr and 72 hr, respectively, after transfection.
ESCs (23 105) were infected with the virus twice, selected by 1.5 mg/ml puro-
mycin for 7–10 days, clones were picked, and stable KD ESC lines obtained.
Tet1/Tet2 KD ESCs were puro resistance and, for Dnmt3b KD, the neo resis-
tance was used to substitute the pSIREN-RetroQ puro resistance, ESCs then
selected with 500 mg/ml G-418 for 7 days, and the stable KD clones picked.
Telomere QFISH
Telomere length and function (telomere integrity and chromosome stability)
was estimated by telomere QFISH (Hande et al., 1999; Herrera et al., 1999;
Huang et al., 2011; Poon et al., 1999; Zijlmans et al., 1997). Cells were incu-
bated with 0.3 mg/ml nocodazole for 3 hr to enrich cells at metaphases. Meta-
phase-enriched cells were exposed to hypotonic treatment with 75 mM KCl
solution, fixed with methanol:glacial acetic acid (3:1), and spread onto clean
slides. Telomere FISH and quantification were performed as described previ-
ously (Herrera et al., 1999; Poon et al., 1999), except for fluorescein isothiocy-
anate (FITC)-labeled (CCCTAA) peptide nucleic acid (PNA) probe (Panagene)
used in this study. Telomeres were denatured at 80C for 3 min and hybridized
with telomere PNA probe (0.5 mg/ml). Fluorescence from chromosomes and
telomeres was digitally imaged on Zeiss Axio Imager Z1 microscope with
FITC/DAPI filters, using AxioCam and AxioVision software 4.6. For quantitative
measurement of telomere length, telomere fluorescence intensity was inte-
grated using the TFL-TELO program.
Telomere CO-FISH
Strand-specific CO-FISH was performed based on original publication (Bailey
et al., 2004), with minor modification (detailed in Supplemental Experimental
Procedures).
Telomere Measurement by Quantitative Real-Time PCR
Average telomere lengthwasmeasured from total genomicDNAusing real-time
PCR assay (Callicott and Womack, 2006; Cawthon, 2002; Huang et al., 2011).
MeDIP-qPCR and hMeDIP-qPCR
MeDIP-qPCR and hMeDIP-qPCR experiments and analysis were carried out
as described (Weber et al., 2005).
Analysis of Sub-telomeric DNA Methylation
Analysis of DNA methylation of sub-telomeric genomic DNA regions and
bisulfite sequencing were carried out as described (Gonzalo et al., 2006).
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